We believe Eden Research is making strong progress on several fronts, expanding and developing the commercial opportunity for Mevalone, expecting to achieve full EU authorisation for Ecovelex in the near term and progressing commercial discussions with potential partners for its insecticide product. The current marketed and late-stage pipeline has a market potential of c€190m to the company, offering significant growth opportunity. With regulatory approved products on the market, Eden Research i ....
02 Feb 2026
Eden Research - Growing opportunity
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Eden Research - Growing opportunity
Eden Research plc (EDEN:LON) | 4.0 0 1.3% | Mkt Cap: 21.1m
- Published:
02 Feb 2026 -
Author:
Chris Donnellan -
Pages:
28 -
We believe Eden Research is making strong progress on several fronts, expanding and developing the commercial opportunity for Mevalone, expecting to achieve full EU authorisation for Ecovelex in the near term and progressing commercial discussions with potential partners for its insecticide product. The current marketed and late-stage pipeline has a market potential of c€190m to the company, offering significant growth opportunity. With regulatory approved products on the market, Eden Research i ....